Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy CD ROM Electronic (PDF) Site License Enterprisewide Chinas Pharmaceutical Industry - Porters Five Forces Strategy Analysis Aruvian Research, March 2008, Pages: 20   Description     Table of Contents        Enquire before Buying    Send to a Friend   The Chinese pharmaceuticals market is forecast to become the worlds firth largest by 2010 - and the largest by 2050. There are still greater market access following Chinas entry into the World Trade Organization (WTO), multinational investors continue to face a range of obstacles, many of which stem from the legacy of central planning of the industry. These include complex distribution, under-developed retail options, intellectual property infringements and pricing controls and pressures. At the same time, the continuing reliance of leading domestic companies on generic drugs has prevented the emergence of Chinese brands. However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Aruvian Research analyzes China’s Pharmaceutical Industry in Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macro-environment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace. Customers who bought this item also bought Japanese Pharmaceutical Industry: An Analysis Otsuka Pharmaceutical Co Deals Briefing Pharmaceutical Industry in the United States Chinese Pharmaceutical Industry Chinas Guidebook for Pharmaceutical Patent Protection The Pharmaceutical Market: Saudi Arabia Business Opportunities in China: the Impact of the WTO 2nd Edition The Pharmaceutical Market: Ukraine

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster